PLALAB PLACENTA SKIN BOOSTER- niacinamide, adenosine liquid 
RENOCELL Co., Ltd

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

Plalab Placenta Skin Booster

Niacinamide (2%)
Adenosine (0.04%)

Skin Protectant

Keep out of reach of children
 Do not swallow. In case of accidental ingestion, seek professional assistance.

Moisturizes skin. Keep skin soft and smooth and helps to improve skin elasticity. Whitening and wrinkle care.

Warnings
For external use only
Do not use when Your skin is red, inflamed, irritated or painful
When using this product
 Do not apply on other parts of the body
 Avoid contact with eyes. If contact occurs, rinse eyes thoroughly with water.
 Do not apply directly to wound or open cut.
Stop use and ask doctor if rash or irritation on skin develops and lasts.
Store at room temperature 

Directions
After washing the face, apply the adequate amount with a cotton pad.

Water, Glycerin, Butylene Glycol, Placental Protein, Sodium Hyaluronate, 1,2-Hexanediol, PEG/PPG-17/6 Copolymer, Morus Alba Bark Extract, Arbutin, Ascorbic Acid, Sodium Citrate, Citric Acid, PPG-26-Buteth-26, PEG-40 Hydrogenated Castor Oil, Caprylic/Capric Triglyceride, Deoxyphytantriyl Palmitamide MEA, Hydrogenated Lecithin, Ceramide NP, Cholesterol, Fragrance

Plalab Placenta Skin Booster

skin booster

PLALAB PLACENTA SKIN BOOSTER 
niacinamide, adenosine liquid
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:70326-105
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
NIACINAMIDE (UNII: 25X51I8RD4) (NIACINAMIDE - UNII:25X51I8RD4) NIACINAMIDE0.02   in 120 mL
ADENOSINE (UNII: K72T3FS567) (ADENOSINE - UNII:K72T3FS567) ADENOSINE0.0004   in 120 mL
Inactive Ingredients
Ingredient NameStrength
water (UNII: 059QF0KO0R)  
GLYCERIN (UNII: PDC6A3C0OX)  
Butylene Glycol (UNII: 3XUS85K0RA)  
SUS SCROFA PLACENTA (UNII: C8CV8867O8)  
HYALURONATE SODIUM (UNII: YSE9PPT4TH)  
1,2-HEXANEDIOL (UNII: TR046Y3K1G)  
PEG/PPG-17/6 COPOLYMER (UNII: P5QZM4T259)  
MORUS ALBA BARK (UNII: 7O71A48NDP)  
ARBUTIN (UNII: C5INA23HXF)  
Ascorbic Acid (UNII: PQ6CK8PD0R)  
DISODIUM HYDROGEN CITRATE (UNII: 6FO62KCQ7A)  
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)  
PPG-26-Buteth-26 (UNII: 2II1K6TZ4P)  
POLYOXYL 40 HYDROGENATED CASTOR OIL (UNII: 7YC686GQ8F)  
MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)  
DEOXYPHYTANTRIYL (2-HYDROXYETHYL)PALMITAMIDE (UNII: XY03VF410D)  
HYDROGENATED SOYBEAN LECITHIN (UNII: H1109Z9J4N)  
CERAMIDE NP (UNII: 4370DF050B)  
CHOLESTEROL (UNII: 97C5T2UQ7J)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:70326-105-021 in 1 PACKAGE
1NDC:70326-105-01120 mL in 1 BOTTLE, PUMP; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other12/23/2015
Labeler - RENOCELL Co., Ltd (689605795)
Registrant - RENOCELL Co., Ltd (689605795)
Establishment
NameAddressID/FEIBusiness Operations
RENOCELL Co., Ltd689605795manufacture(70326-105)

Revised: 12/2015
Document Id: e71b23a4-4884-4a52-8697-fe382f16db3b
Set id: 0a1bf4f1-5762-4d36-afb9-82a02314f2a8
Version: 3
Effective Time: 20151224
 
RENOCELL Co., Ltd